onlinebingonodepositbonus| Cornerstone Pharmaceuticals-B reaches a commercial strategic cooperation with European pharmaceutical company Ewpharma

27 05
Author:editor|Category:Tourism

Cornerstone Pharmaceuticals-B (02616) issued an announcementonlinebingonodepositbonus, reached a commercial strategic cooperation with European pharmaceutical company Ewpharmaonlinebingonodepositbonus, awarded Ewopharma the commercialization rights of sugliximab in Central and Eastern Europe. Under the Licensing and Commercialization Agreement, Ewopharma will receive the rights to commercialize suglimab in Switzerland and 18 Central and Eastern European Countries (CEEs).

onlinebingonodepositbonus| Cornerstone Pharmaceuticals-B reaches a commercial strategic cooperation with European pharmaceutical company Ewpharma

Under the terms of the licensing and commercialization agreement, Cornerstone Pharmaceuticals will receive a down payment of up to US$51.3 million and subsequent registration and sales milestone payments. Cornerstone Pharmaceuticals will generate international revenue by selling products to Ewopharma and its subsidiaries. Ewopharma will be responsible for pricing, reimbursement, marketing, distribution and other related matters, while Cornerstone Pharmaceuticals will be responsible for supplying products and providing necessary training and support to relevant brands.

View14 Comments0
Back
Category
Back
Index
radicatripleplaypoker| Institutional asset allocation forecasts spark market speculation that Bitcoin prices will soar to millions of dollars? bestonlinecasinothatacceptspaypal| Hua Chunying became Vice Foreign Minister and is my country's third female Vice Foreign Minister